1-8 of 8
Zhen-Yi Wang
Close
Sort by
Journal Articles

LICs Of APL-Like Leukemia Lead a Step-Wise and Divergent Differentiation Course

Xiang-Zhen Liu, Jian-Min Dai, Fei Ding, Jing Ding, Juan Chen, Ning Guo, Wu Zhang, Jun-ming Li, Sai-juan Chen, Zhu Chen, Zhen-Yi Wang, Jiang Zhu
Journal: Blood
Blood (2013) 122 (21): 5405.
https://doi.org/10.1182/blood.V122.21.5405.5405
Published: 2013
Journal Articles

Front-Line Therapy with Arsenic Trioxide/All- Trans -Retinoic Acid Combination and Chemotherapy Improves Cure Rates in Newly Diagnosed Patients with Acute Promyelocytic Leukemia

Jiong Hu, MD, Yuan-fang Liu, Chuan-feng Wu, Guang-biao Zhou, Zhi-Xiang Shen, Jun-min Li, Zhen-Yi Wang, Sai-Juan Chen, Zhu Chen
Journal: Blood
Blood (2008) 112 (11): 2970.
https://doi.org/10.1182/blood.V112.11.2970.2970
Published: 2008
Journal Articles

Acute promyelocytic leukemia: from highly fatal to highly curable

Zhen-Yi Wang, Zhu Chen
Journal: Blood
Blood (2008) 111 (5): 2505–2515.
https://doi.org/10.1182/blood-2007-07-102798
Published: 2008
Journal Articles

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Guang-Biao Zhou, Hui Kang, Lan Wang, Li Gao, Ping Liu, Jun Xie, Feng-Xiang Zhang, Xiang-Qin Weng, Zhi-Xiang Shen, Jue Chen, Long-Jun Gu, Ming Yan, Dong-Er Zhang, Sai-Juan Chen, Zhen-Yi Wang, Zhu Chen
Journal: Blood
Blood (2006) 109 (8): 3441–3450.
https://doi.org/10.1182/blood-2006-06-032250
Published: 2006
Includes: Supplemental data
Journal Articles

Phase I Clinical Trial of Glivec in Combination with Tetra-Arsenic Tetra-Sulfide in the Treatment of CML Patients in Advanced Phase.

Jun-Min Li, Ai-Hua Wang, Hui-Ping Sun, Yang Shen, Rui-Hua Zhao, Bai-Wei Gu, Bing Chen, Wen Xing, Zhi-Xiang Shen, Zhen-Yi Wang, Sai-Juan Chen, Zhu Chen
Journal: Blood
Blood (2004) 104 (11): 4653.
https://doi.org/10.1182/blood.V104.11.4653.4653
Published: 2004
Journal Articles

Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients

Chao Niu, Hua Yan, Ting Yu, Hui-Ping Sun, Jian-Xiang Liu, Xiu-Song Li, Wen Wu, Fen-Qin Zhang, Yu Chen, Li Zhou, Jun-Min Li, Xiao-Ying Zeng, Ren-Rong Ou Yang, Mi-Man Yuan, Mei-Yu Ren, Feng-Ying Gu, Qi Cao, Bo-Wei Gu, Xin-Ying Su, Guo-Qiang Chen, Shu-Min Xiong, Ting-dong Zhang, Samuel Waxman, Zhen-Yi Wang, Zhu Chen, Jiong Hu, Zhi-Xiang Shen, Sai-Juan Chen
Journal: Blood
Blood (1999) 94 (10): 3315–3324.
https://doi.org/10.1182/blood.V94.10.3315.422k16_3315_3324
Published: 1999
Journal Articles

Use of Arsenic Trioxide (As 2 O 3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): I. As 2 O 3 Exerts Dose-Dependent Dual Effects on APL Cells

Guo-Qiang Chen, Xue-Geng Shi, Wei Tang, Shu-Min Xiong, Jun Zhu, Xun Cai, Ze-Guang Han, Jian-Hua Ni, Gui-Ying Shi, Pei-Ming Jia, Meng-Min Liu, Kai-Li He, Chao Niu, Jun Ma, Peng Zhang, Ting-Dong Zhang, Pascale Paul, Tomoki Naoe, Kunio Kitamura, Wilson Miller, Samuel Waxman, Zhen-Yi Wang, Hugues de The, Sai-Juan Chen, Zhu Chen
Journal: Blood
Blood (1997) 89 (9): 3345–3353.
https://doi.org/10.1182/blood.V89.9.3345
Published: 1997
Journal Articles

Use of Arsenic Trioxide (As 2 O 3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

Zhi-Xiang Shen, Guo-Qiang Chen, Jian-Hua Ni, Xiu-Shong Li, Shu-Min Xiong, Qian-Yao Qiu, Jun Zhu, Wei Tang, Guan-Lin Sun, Kan-Qi Yang, Yu Chen, Li Zhou, Zhi-Wen Fang, Yan-Ting Wang, Jun Ma, Peng Zhang, Ting-Dong Zhang, Sai-Juan Chen, Zhu Chen, Zhen-Yi Wang
Journal: Blood
Blood (1997) 89 (9): 3354–3360.
https://doi.org/10.1182/blood.V89.9.3354
Published: 1997